XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications during a Long-Term Follow-Up

XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications during a Long-Term Follow-Up

This study aimed to analyze the surgical and refractive outcomes of XEN glaucoma implant (Allergan, an Abbvie company, Irvine, CA, USA), a minimally invasive surgical device for the treatment of operated uncontrolled glaucoma. Eyes that received XEN Gel Stent placement from December 2014 to October...

Full description

Saved in:
Bibliographic Details
Main Authors: Katarzyna Lewczuk, Joanna Konopińska, Joanna Jabłońska, Jacek Rudowicz, Patrycja Laszewicz, Zofia Mariak, Marek Rękas
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2021/2321922
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items